Bioventix Share Discussion Threads

[housemartin2] 08/10/2015 14:15

Boros10 - are you saying that BVXP are late to market ('Abbott & Roche already launched in Europe')?

[boros10] 08/10/2015 13:49

Bioventix partner for the high sensitive Troponin analyte diagnostic partner is a top 5 player but it is not Abbott or Roche. I believe the partner is Beckman Coulter. Abbott and Roche have already launched in Europe but no one has yet secured FDA approval for the U.S. market. FinnCap's last research note said Troponin royalties could dwarf all the Company's existing royalties.

[igbertsponk] 08/10/2015 11:20

Current leader in troponin tests seem to be Roche, who are a Bioventix customer.

[johnsmith321] 08/10/2015 11:18

Some cardiac troponin-I tests are using other companies antibodies, others are using the bioventix antibody such as BECKMAN COULTER. It will be a large market. As it will be the gold standard test for heart attacks once fully approved by the various agencies such as the FDA.

[stepone68] 08/10/2015 10:40

Do we know for certain that the test being discussed is using the Bioventix product ?

[igbertsponk] 08/10/2015 10:13

Daily Mail as well as BBC

[superstardj] 08/10/2015 08:56

Blood test breakthrough could rule out heart attacks
By PA, Oct 8th 2015 09:57 AM 4 comments

A simple blood test could rule out heart attacks in patients complaining of chest pain and "dramatically" reduce unnecessary admissions to hospital, scientists have found.

Researchers said the high sensitivity test could rule out a heart attack diagnosis in nearly two thirds of people who arrive at accident and emergency (A&E) departments, meaning they could be sent home without needing to be admitted.

Acute chest pain is one of the most common causes of hospital admissions and is responsible for one million visits to A&E wards in the UK, according to the study published in the Lancet medical journal.

The test measures a protein called troponin in the patient's blood, with low levels suggesting they are at "very low risk" of an attack within the following 30 days.

Lead author Dr Anoop Shah from the University of Edinburgh, said: "Until now there were no quick ways to rule out a heart attack within the emergency department.

"Over the last two decades the number of hospital admissions due to chest pain has tripled. The overwhelming majority of these patients do not have a heart attack. We have identified a cardiac troponin concentration below which patients are at very low risk of heart attack either during the admission or in the ensuing 30 days. These patients are therefore potentially suitable for immediate and safe discharge from the emergency department. These findings could dramatically reduce unnecessary hospital admissions and provide substantial cost savings for healthcare providers."

The study, funded by the British Heart Foundation, used the test to measure troponin levels in more than 6,000 patients at four hospitals in Scotland and the US. It found 61% of people had a troponin concentration of less than five nanograms per decilitre - meaning there was a 99.6% likelihood they were at minimal risk of an attack.

[boros10] 05/10/2015 09:40

Stepone68 - your analysis is spot on. I think on this occasion finnCap may have got it wrong.

[igbertsponk] 05/10/2015 08:46

Great results, and so full of future info. Reads to me like they're signalling a drop in revenues from existing stuff 2017 onwards but are confident that others will replace the sales.
Good to see such a step change in the divi payout relatively soon after listing.
Definitely a share to sit on and keep quiet about!

[superstardj] 05/10/2015 08:29

Probably also worth pointing out that last year's results had £190k of backdated royalty income in them. Albeit offset at the profit line by £169k of float and listing costs for the move up to AIM.

[tadders2] 05/10/2015 08:08

Just bought some more.

[housemartin2] 05/10/2015 07:49

Ok, I still can't find the flaw here !
How many companies think about prospects in 2030. (Probably better than mine )

I am surprised Private Equity is not sniffing around to destroy this company - what no debt ? thinking of the future ?

[valustar1] 05/10/2015 07:39

Delighted with 50% divi increase

And interim next year

[apfindley] 04/9/2015 08:27

Looking goodAnd GWMO poised too as news coming

[impvesta] 04/9/2015 07:56

Yes, a cracking trading update this morning:

[housemartin2] 04/9/2015 07:41

The stock that keeps on giving. 20%+ YoY - I can live with that !

[igbertsponk] 04/9/2015 07:26

"Significantly ahead"Yippee!

[impvesta] 11/8/2015 08:21

I think you are preaching to the converted valustar1. That's why we are all waiting quietly and patiently with no comment for 3 weeks until you broke the silence!